Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Medical Genetics

The Genetic Blueprint of FCCM

At a Glance

Familial Cerebral Cavernous Malformation (FCCM) is caused by a genetic mutation in the CCM1, CCM2, or CCM3 genes. These mutations weaken brain blood vessels, leading to lesions. Genetic testing can identify your specific mutation, guide your monitoring, and help with family planning.

The biology of Familial Cerebral Cavernous Malformation (FCCM) is rooted in your DNA. While every person has three specific genes designed to keep their blood vessels strong and “tight,” people with FCCM have a change (mutation) in one of them [1]. These three genes—CCM1 (also called KRIT1), CCM2, and CCM3—work together like a construction crew to build and maintain the walls of the small blood vessels in your brain [1][2].

The Three Genes: Different Roles, Same Goal

Think of these three genes as a team that creates the “glue” holding your vessel walls together [1].

  • CCM1 (KRIT1) and CCM2: These genes primarily prevent the blood vessel cells from becoming too reactive or disorganized [3]. When they aren’t working, the cells lose their shape and the vessel walls become unstable [4][5].
  • CCM3 (PDCD10): This gene is often described as the most “aggressive” of the three [6]. It handles more complex tasks, like managing how cells grow and recycle themselves [7]. Because its job is so vital, mutations in CCM3 often lead to an earlier age of onset (sometimes in childhood) and a higher number of lesions compared to mutations in CCM1 or CCM2 [6][8]. Patients with this specific mutation may also have small, harmless mineral deposits (calcifications) in their adrenal glands [9][6].

The ‘Two-Hit Hypothesis’: Why Lesions Form

You might wonder why, if the mutation is in all your cells, you only have lesions in certain spots. This is explained by the two-hit hypothesis [10]:

  1. The First Hit: This is the mutation you were born with. It is present in every cell of your body, but because you have a second, healthy copy of the gene, your blood vessels mostly function normally [10][11].
  2. The Second Hit: Over time, a completely random, accidental biological change occurs in a single cell in the brain, disabling the second, healthy copy of the gene [10]. Now that cell has no working “glue” at all. That single cell begins to grow into a cluster of leaky vessels—the cavernous malformation [10][11].

Because every cell in an FCCM patient already has the “first hit,” it only takes one random “second hit” to start a lesion [10]. This is why people with FCCM tend to develop multiple lesions over their lifetime, whereas people without the genetic form would need two random accidents to happen in the exact same cell—a much rarer event [10][11]. It is very important to understand that this “second hit” is not caused by your diet, stress, or lifestyle choices—it is purely a random biological event [10].

The Common Hispanic Mutation (CHM)

In the Southwestern United States, particularly among families with Mexican heritage in New Mexico and Colorado, there is a well-known genetic pattern called the Common Hispanic Mutation [12][13]. This is a “founder mutation” in the CCM1 gene that has been passed down through generations [12]. Patients with this specific mutation often have a high number of brain lesions and may have small, blue-tinted spots on their skin [13].

The Role of Genetic Testing and Counseling

Genetic testing is a simple blood or saliva test that identifies which of the three genes is affected [1]. This information is a powerful tool for your care:

  • Precision Monitoring: Knowing your gene type helps doctors predict if you are at higher risk for new lesions or seizures [14].
  • Family Planning: A genetic counselor can help you understand the 50% chance of passing the mutation to children and discuss options for family planning, including In Vitro Fertilization (IVF) with Preimplantation Genetic Testing (PGT), which allows you to screen embryos for the mutation before pregnancy [15][16].
  • Screening Relatives: Once your specific mutation is found, your siblings or children can be tested with 100% accuracy to see if they need their own monitoring plan [1][17].

Genetic counseling isn’t just about data; it’s about supporting you through the emotional and practical impact of this information [18]. Understanding your blueprint is the best way to build a proactive plan for your health.

To learn more about how these genetic changes show up in the body, read Recognizing Symptoms and Warning Signs.

Common questions in this guide

What genes cause Familial Cerebral Cavernous Malformation?
FCCM is caused by a mutation in one of three genes: CCM1 (KRIT1), CCM2, or CCM3 (PDCD10). These genes normally work together to maintain strong blood vessel walls in the brain, but a mutation makes the vessels weak and prone to leaking.
What is the two-hit hypothesis in FCCM?
The two-hit hypothesis explains why lesions only form in certain areas. You are born with one genetic mutation in all your cells, and a second random, biological accident happens in a single cell later in life. That second hit leaves the cell with no working genes, triggering a lesion to grow.
How does having a CCM3 mutation affect FCCM?
The CCM3 gene plays a critical role in managing cell growth. Mutations in this gene often lead to an earlier age of onset, sometimes in childhood, and a higher number of brain lesions compared to CCM1 or CCM2 mutations.
Should my family members get genetic testing for FCCM?
Once your specific gene mutation is identified, your siblings and children can be tested using a simple blood or saliva test. This helps determine if they carry the same mutation and need to establish their own proactive monitoring plan.
Can genetic testing help with family planning if I have FCCM?
Yes, genetic testing allows you to explore options with a genetic counselor. This includes procedures like In Vitro Fertilization (IVF) with Preimplantation Genetic Testing (PGT) to screen embryos for the FCCM mutation before pregnancy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which of the three genes (CCM1, CCM2, or CCM3) was identified in my genetic test?
  2. 2.If I have the CCM3 mutation, how should my monitoring schedule differ from someone with CCM1 or CCM2?
  3. 3.Should my siblings or children be tested, and at what age is it appropriate to start?
  4. 4.How do my genetic results help predict the likelihood of new lesions forming in the future?
  5. 5.Are there specific specialists you recommend I see for my genetic counseling?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report.

    Ishii K, Tozaka N, Tsutsumi S, et al.

    Medicine 2020; (99(29)):e19800 doi:10.1097/MD.0000000000019800.

    PMID: 32702807
  2. 2

    Is Location Everything? Regulation of the Endothelial CCM Signaling Complex.

    Swamy H, Glading AJ

    Frontiers in cardiovascular medicine 2022; (9()):954780 doi:10.3389/fcvm.2022.954780.

    PMID: 35898265
  3. 3

    The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity.

    Lisowska J, Rödel CJ, Manet S, et al.

    Journal of cell science 2018; (131(15)) doi:10.1242/jcs.216093.

    PMID: 30030370
  4. 4

    Oscillatory contractile forces refine endothelial cell-cell interactions for continuous lumen formation governed by Heg1/Ccm1.

    Yin J, Maggi L, Wiesner C, et al.

    Angiogenesis 2024; (27(4)):845-860 doi:10.1007/s10456-024-09945-5.

    PMID: 39249713
  5. 5

    Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium.

    Goitre L, DiStefano PV, Moglia A, et al.

    Scientific reports 2017; (7(1)):8296 doi:10.1038/s41598-017-08373-4.

    PMID: 28811547
  6. 6

    Clinicoradiologic data of familial cerebral cavernous malformation with age-related disease burden.

    Kim S, Moon J, Jung KH, et al.

    Annals of clinical and translational neurology 2023; (10(3)):373-383 doi:10.1002/acn3.51728.

    PMID: 36629374
  7. 7

    Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3.

    Schwefel K, Spiegler S, Kirchmaier BC, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020; (34(7)):9018-9033 doi:10.1096/fj.201902888R.

    PMID: 32515053
  8. 8

    Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations.

    Galvão GDF, Trefilio LM, Salvio AL, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2024; (33(11)):107947 doi:10.1016/j.jstrokecerebrovasdis.2024.107947.

    PMID: 39181174
  9. 9

    Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition.

    Strickland CD, Eberhardt SC, Bartlett MR, et al.

    Radiology 2017; (284(2)):443-450 doi:10.1148/radiol.2017161127.

    PMID: 28318403
  10. 10

    Cerebral Cavernous Malformation: From Mechanism to Therapy.

    Snellings DA, Hong CC, Ren AA, et al.

    Circulation research 2021; (129(1)):195-215 doi:10.1161/CIRCRESAHA.121.318174.

    PMID: 34166073
  11. 11

    Endothelial cell clonal expansion in the development of cerebral cavernous malformations.

    Malinverno M, Maderna C, Abu Taha A, et al.

    Nature communications 2019; (10(1)):2761 doi:10.1038/s41467-019-10707-x.

    PMID: 31235698
  12. 12

    Increased number of white matter lesions in patients with familial cerebral cavernous malformations.

    Golden MJ, Morrison LA, Kim H, Hart BL

    AJNR. American journal of neuroradiology 2015; (36(5)):899-903 doi:10.3174/ajnr.A4200.

    PMID: 25556204
  13. 13

    Cutaneous findings of familial cerebral cavernous malformation syndrome due to the common Hispanic mutation.

    Manole AK, Forrester VJ, Zlotoff BJ, et al.

    American journal of medical genetics. Part A 2020; (182(5)):1066-1072 doi:10.1002/ajmg.a.61519.

    PMID: 32100472
  14. 14

    Seizure Incidence Rates in Children and Adults With Familial Cerebral Cavernous Malformations.

    Fox CK, Nelson J, McCulloch CE, et al.

    Neurology 2021; (97(12)):e1210-e1216 doi:10.1212/WNL.0000000000012569.

    PMID: 34389651
  15. 15

    Identification of a Novel Deletion Mutation (c.1780delG) and a Novel Splice-Site Mutation (c.1412-1G>A) in the CCM1/KRIT1 Gene Associated with Familial Cerebral Cavernous Malformation in the Chinese Population.

    Yang C, Zhao J, Wu B, et al.

    Journal of molecular neuroscience : MN 2017; (61(1)):8-15 doi:10.1007/s12031-016-0836-2.

    PMID: 27649701
  16. 16

    A novel CCM1/KRIT1 heterozygous deletion mutation (c.1919delT) in a Chinese family with familial cerebral cavernous malformation.

    Yang C, Wu B, Zhong H, et al.

    Clinical neurology and neurosurgery 2018; (164()):44-46 doi:10.1016/j.clineuro.2017.11.005.

    PMID: 29169046
  17. 17

    Molecular diagnostic workflow, clinical interpretation of sequence variants, and data repository procedures in 140 individuals with familial cerebral cavernous malformations.

    Fusco C, Copetti M, Mazza T, et al.

    Human mutation 2019; (40(11)):e24-e36 doi:10.1002/humu.23851.

    PMID: 31254430
  18. 18

    Quality of life and mood assessment in conservatively treated cavernous malformation-related epilepsy.

    Rauschenbach L, Bartsch P, Santos AN, et al.

    Brain and behavior 2022; (12(6)):e2595 doi:10.1002/brb3.2595.

    PMID: 35470577

This page provides educational information about the genetics of FCCM. It is not a substitute for professional genetic counseling or medical advice from your healthcare team.

Get notified when new evidence is published on Familial cerebral cavernous malformation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.